Tian, X. et al. 2024. Effect of Apatinib Mesylate on Clinical Remission Rate and Adverse Reactions in Patients with Advanced Primary Hepatocellular Carcinoma. International Journal of Biology and Life Sciences. 5, 1 (Feb. 2024), 13–16. DOI:https://doi.org/10.54097/t3s4wp88.